Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Thomas

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of the American Heart Association|February 3, 2022
Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular DeathPaul F Brady, Winnie Chua, Frantisek Nehaj, et al.
Vascular Pharmacology|January 31, 2023
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromesWilliam A E Parker, Dominick J Angiolillo, Fabiana Rollini, et al.
Learning Health Systems|October 20, 2023
Modelling clinical narrative as computable knowledge: The NICE computable implementation guidance projectPhilip Scott, Michaela Heigl, Charles McCay, et al.
Thrombosis and Haemostasis|May 27, 2019
Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled TrialSalahaddin Ubaid, Thomas J Ford, Colin Berry, et al.
The Plant Journal : for Cell and Molecular Biology|September 17, 2013
Genetic dissection of a TIR-NB-LRR locus from the wild North American grapevine species Muscadinia rotundifolia identifies paralogous genes conferring resistance to major fungal and oomycete pathogens in cultivated grapevineAngela Feechan, Claire Anderson, Laurent Torregrosa, et al.
Thrombosis and Haemostasis|March 17, 2017
Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes statusMark R Thomas, Dominick J Angiolillo, Marc P Bonaca, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in HumansAhmed Iqbal, Lynne R Prince, Peter Novodvorsky, et al.
Journal of the American College of Cardiology|March 12, 2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 TrialRobert F Storey, Dominick J Angiolillo, Marc P Bonaca, et al.
Haematologica|July 21, 2018
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VIPhillip L R Nicolson, Craig E Hughes, Stephanie Watson, et al.
Journal of Thrombosis and Haemostasis : JTH|August 4, 2023
Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapyFawaz O Alenazy, Maan H Harbi, Dean P Kavanagh, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of the American Heart Association|February 3, 2022
Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular DeathPaul F Brady, Winnie Chua, Frantisek Nehaj, et al.
Vascular Pharmacology|January 31, 2023
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromesWilliam A E Parker, Dominick J Angiolillo, Fabiana Rollini, et al.
Learning Health Systems|October 20, 2023
Modelling clinical narrative as computable knowledge: The NICE computable implementation guidance projectPhilip Scott, Michaela Heigl, Charles McCay, et al.
Thrombosis and Haemostasis|May 27, 2019
Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled TrialSalahaddin Ubaid, Thomas J Ford, Colin Berry, et al.
The Plant Journal : for Cell and Molecular Biology|September 17, 2013
Genetic dissection of a TIR-NB-LRR locus from the wild North American grapevine species Muscadinia rotundifolia identifies paralogous genes conferring resistance to major fungal and oomycete pathogens in cultivated grapevineAngela Feechan, Claire Anderson, Laurent Torregrosa, et al.
Thrombosis and Haemostasis|March 17, 2017
Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes statusMark R Thomas, Dominick J Angiolillo, Marc P Bonaca, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in HumansAhmed Iqbal, Lynne R Prince, Peter Novodvorsky, et al.
Journal of the American College of Cardiology|March 12, 2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 TrialRobert F Storey, Dominick J Angiolillo, Marc P Bonaca, et al.
Haematologica|July 21, 2018
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VIPhillip L R Nicolson, Craig E Hughes, Stephanie Watson, et al.
Journal of Thrombosis and Haemostasis : JTH|August 4, 2023
Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapyFawaz O Alenazy, Maan H Harbi, Dean P Kavanagh, et al.
Pageof 8